# BionicM

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bionicm

- Industry: Medical Devices & Equipment
- Headquarters: Tokyo, Japan
- Website: www.bionicm.com
- Total disclosed funding: $8.9M
- Latest round: Series A (Jan 31, 2023)
- Investors on record: 8

## About

BionicM Inc., based in Japan, develops advanced prosthetic solutions that enhance mobility for amputees through innovative robotic technology designed for improved user experience and functionality.Founded in 2018, BionicM Inc. is located in Tokyo, Japan, focusing on the creation of robotic prosthetic limbs. The company has successfully completed 4 deals, with its latest funding round in September 2024, raising JPY 3.000 mn. Co-founded by Sunny Sun and Xiaojun Sun, who serves as CEO, the company has remained focused without notable pivots in business strategy.BionicM specializes in the development of advanced prosthetic solutions designed to restore mobility and enhance the quality of life for amputees. Their core product offerings include state-of-the-art robotic prosthetic limbs that are equipped with cutting-edge technology, providing users with a more natural range of motion and improved functionality. These prosthetics utilize sophisticated sensors and algorithms to mimic the dynamics of human movement, thereby optimizing user experience in daily activities such as walking, running, and climbing stairs. The company primarily serves individuals with lower limb amputations, rehabilitation centers, and healthcare providers, focusing on markets across North America, Europe, and parts of Asia. Since their launch, these products have garnered attention for their innovative approach to addressing the challenges faced by amputees, ensuring that the end users can lead more active and independent lives.BionicM generates revenue through direct sales of its robotic prosthetic limbs and associated services, operating primarily on a business-to-consumer (B2C) model, as well as partnerships with healthcare institutions and rehabilitation centers. Transactions typically involve clients purchasing the prosthetic devices, often accompanied by thorough consultations and fittings to ensure optimal performance and comfort. The company may implement a pricing structure that includes one-time payments for the devices, along with potential subscription models for ongoing support and maintenance services. Flagship products, recognized for their innovative design and functionality, command a premium within the prosthetic market. The established relationships with healthcare professionals and organizations facilitate the distribution and accessibility of their products to a broader client base.Following a recent funding round in September 2024, where BionicM Inc. raised USD 3 million from individual investors, the company plans to accelerate its business and expand its market presence. The funding will be utilized to establish a subsidiary in the United States and to support the development of upcoming new products aimed at enhancing their current offerings. The company is targeting expansion into new geographic regions that include North America and parts of Europe by the end of 2025.

## Funding rounds

- Series A, Jan 31, 2023, $2.9M — Chibagin Capital, SBI Shinsei Corporate Investment, UTokyo Innovation Platform, AIS CAPITAL, Kiraboshi Capital, NVenture Capital
- Series A, Sep 7, 2020, $5.2M — University of Tokyo Edge Capital Partners, Japan Science and Technology Agency, UTokyo Innovation Platform
- Seed, Feb 21, 2019, $0.9M — University of Tokyo Edge Capital Partners

## Investors

- University of Tokyo Edge Capital Partners (https://capitalatlas.ai/funds/university-of-tokyo-edge-capital-partners) — Seed, Series A
- Japan Science and Technology Agency — Series A
- UTokyo Innovation Platform (https://capitalatlas.ai/funds/utokyo-innovation-platform) — Series A
- Chibagin Capital (https://capitalatlas.ai/funds/chibagin-capital) — Series A
- SBI Shinsei Corporate Investment (https://capitalatlas.ai/funds/sbi-shinsei-corporate-investment) — Series A
- AIS CAPITAL (https://capitalatlas.ai/funds/ais-capital) — Series A
- Kiraboshi Capital (https://capitalatlas.ai/funds/kiraboshi-capital) — Series A
- NVenture Capital (https://capitalatlas.ai/funds/nventure-capital) — Series A